RESUMO
INTRODUCTION: It has been reported that the time between symptom onset and objective diagnosis of pulmonary embolism (PE) does not affect patients' prognosis with regard to re-thrombosis and mortality risk. However, this observation is contra-intuitive and poorly understood. We further elaborated on this paradox by evaluating thrombus load and right ventricular function in patients with and without diagnostic delay. MATERIALS AND METHODS: We performed a post hoc analysis of a previously published observational prospective outcome study in 113 consecutive PE patients. Qanadli-score and RV/LV ratio were scored in all patients, as was the duration from symptom onset to clinical presentation and diagnosis. Diagnostic delay was defined as a period of more than 7 days between symptom onset and clinical presentation. Further endpoints were mortality and hospital readmission in a 6-week follow-up period. RESULTS: Twenty patients with and 93 patients without delay were studied, who had comparable baseline characteristics and co-morbidities. In linear analyses, Qanadli-score (R² of 0.021; P = 0.130) and RV/LV ratio (R² < 0.001; P = 0.991) were not associated with diagnostic delay. Likewise, longer delay was not predictive of 6-week mortality (odds ratio, 0.65; 95% CI, 0.08-5.57) or hospital readmission (odds ratio, 0.75; 95% CI, 0.15-3.65). CONCLUSION: In our patient cohort, diagnostic delay was not associated with higher thrombus load or right ventricular dysfunction. This provides a possible explanation for the lack of prognostic relevance of diagnostic delay.
Assuntos
Embolia Pulmonar/fisiopatologia , Trombose/fisiopatologia , Função Ventricular Direita , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Embolia Pulmonar/diagnósticoRESUMO
INTRODUCTION: The Wells clinical decision rule (CDR) and D-dimer tests can be used to exclude pulmonary embolism (PE). We performed a meta-analysis to determine the negative predictive value (NPV) of an "unlikely" CDR (Assuntos
Produtos de Degradação da Fibrina e do Fibrinogênio/metabolismo
, Embolia Pulmonar/diagnóstico por imagem
, Embolia Pulmonar/diagnóstico
, Segurança
, Anticoagulantes/uso terapêutico
, Doenças Autoimunes/complicações
, Doenças Autoimunes/diagnóstico por imagem
, Doenças Autoimunes/tratamento farmacológico
, Biomarcadores/sangue
, Celulite (Flegmão)/complicações
, Celulite (Flegmão)/diagnóstico por imagem
, Celulite (Flegmão)/tratamento farmacológico
, Coagulantes
, Feminino
, Humanos
, Incidência
, Jurisprudência
, MEDLINE
, Masculino
, Pessoa de Meia-Idade
, Probabilidade
, Estudos Prospectivos
, Embolia Pulmonar/sangue
, Radiografia
, Recidiva
, Tromboembolia Venosa/sangue
RESUMO
The initial 300 patients whose symptomatic cholelithiasis was managed by laparoscopic cholecystectomy (LC) were matched to and compared with 300 patients managed by open cholecystectomy (OC) during the 30 months prior to the introduction of LC. Of the 300 LC attempted 292 (97.3%) were successful with conversion to OC rate of 2.7%. Besides the obviously better cosmetic results, LC patients had less post operative pain, mean doses of opiates needed 0.01 versus 5 for OC (p < 0.0001), were discharged earlier from the hospital, mean 3.1 days versus 8 days for OC (p < 0.001) and had less postoperative complications 4% versus 11% for OC. We conclude that not only is LC a better operation than OC, but also that in the regional referral centres such as ours, LC can safely supplant OC as the preferred modality for the management of symptomatic cholelithiasis.